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doi:10.1Objective: Intracardiac beating-heart procedures require the introduction and exchange of complex instruments
and devices. To prevent potential complications such as air embolism and bleeding, a universal cardioport was
designed and tested.
Methods: The design consists of a port body and a series of interchangeable sleeves. The port uses a fluid purg-
ing system to remove air from the instrument before insertion into the heart, and a valve systemminimizes blood
loss during instrument changes.
Results: The cardioport was tested ex vivo and in vivo in pigs (n ¼ 5). Beating-heart procedures, such as septal
defect closure and mitral valve repair, were modeled. Ex vivo trials (n¼ 150) were performed, and no air emboli
were introduced using the port. In comparison, air emboli were detected in 40% to 85% of the cases without the
use of the port-based purging system. Port operation revealed excellent ergonomics and minimal blood loss.
Conclusions: A novel cardioport system designed to prevent air entry and blood loss from transcardiac instru-
ment introduction was shown to be an enabling platform for intracardiac beating-heart surgery. The port system
improves safety and facilitates further development of complex instruments and devices for transcardiac
beating-heart surgery. (J Thorac Cardiovasc Surg 2011;142:1545-51)Video clip is available online.
Catheter-based intracardiac interventions to treat a variety of
intracardiac and vascular defects have become the preferred
approach formany lesions. Thevariety of devices that can be
delivered via peripheral vessel access into the cardiac cham-
bers has increased over the years largely because of im-
proved manufacturing technology. However, there are
interventional tools and devices that are difficult to deliver
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Speripheral blood vessels by the large size catheters has
been reported.1 Moreover, with a transcatheter peripheral
approach, there is limited precision for device positioning
and manipulation inside the beating heart because of the
moving structures and catheter tip control from the long dis-
tance. These limitations have led surgeons to develop trans-
cardiac approaches for intracardiac procedures. Thus,
transcardiac beating-heart surgical techniques that avoid
use of cardiopulmonary bypass have evolved rapidly over
the past decade and now are becoming more widely ap-
plied.2 In contrast with catheter-based interventions, trans-
cardiac procedures have the advantage of providing
a more direct route for device deployment or tissue manipu-
lation, avoiding the often complex trajectory required for pe-
ripheral access, and providing a more stable tool tip inside
the beating heart. Also, they are not as limited by the size
constraints of peripheral vessels. Various devices can be in-
troduced directly through the heart wall with echocardio-
graphic, fluoroscopic, or magnetic resonance imaging
guidance. For example, transapical left ventricular access
is currently widely applied for aortic valve replacement
and is evenproposed for evolving techniques formitral valve
repair and closure of ventricular septal defects (VSDs).3-7
With an impending growing complexity of the instruments
and devices for transcardiac repair, we anticipate the need to
introduce these instruments safely inside the beating heart,
minimizing blood loss and the risk of introduction of air em-
boli. In addition, depending on the procedure, some surgical
tools may need to be introduced into the cardiac chamberdiovascular Surgery c Volume 142, Number 6 1545
Abbreviations and Acronyms
2D ¼ 2-dimensional
3D ¼ 3-dimensional
VSD ¼ ventricular septal defect
Evolving Technology/Basic Science Vasilyev et al
E
T
/B
Smultiple times during a single procedure. Thus, having the
ability for easy and safe instrument exchange is of potential
benefit. The risk associated with the introduction of large air
bubbles into the cardiac chamber has been associated with
end-organ injury, including stroke.8
The goal of our project was to develop and evaluate a uni-
versal transcardiac port (cardioport) that allows introduc-
tion of a variety of tools and facilitates multiple
instrument insertions and exchanges, but prevents introduc-
tion of air into the cardiac chamber and bleeding during port
placement and instrument exchanges.
MATERIALS AND METHODS
Port Design Requirements and Implementation
The key design requirements for the cardioport included the following:
(1) direct access of surgical tools into any of the cardiac chambers from var-
ious angles; (2) prevention of introduction of air emboli detectable by echo-
cardiography into the heart; (3) minimal blood loss from the heart during
port introduction and operation, as well as during instrument introduction
and exchanges; (4) minimal damage from the port to the heart wall and in-
tracardiac structures; (5) optimal surgical ergonomics to allow single-handFIGURE 1. Fully assembled cardioport. A, Schematic drawing of the port sho
port with one of the tool sleeves inserted. Inset depicts the trileaflet valve at th
1546 The Journal of Thoracic and Cardiovascular Suroperation; and (6) compatibility with imaging modalities that are used for
guidance during beating-heart procedures (ie, ultrasound and fluoroscopy).
These design requirements were incorporated into the components of the
cardioport.9
The design consists of a port body (11 mm in diameter) and a series of
interchangeable sleeves that form the interface between the port and the
matching instrument (Figure 1). The tool sleeves are designed for a variety
of surgical instruments (1–5 mm in diameter) and serve as adapters to stan-
dardize the mating interface between the inner surface of the cardioport
body and the outer surface of each instrument. This design feature serves
primarily to minimize the amount of air inside the port body around an in-
strument or device and at the same time allow smooth instrument move-
ment within the cardioport. To minimize blood loss, a compliant
trileaflet valve was developed and placed at the intracardiac tip of the car-
dioport. On the proximal side of the port, a series of O-rings seal the space
between the instrument, tool sleeve, and body, preventing blood loss and
introduction of air.
An additional design feature that improves safety of the procedure is the
ability to ‘‘visualize’’ the cardioport using ultrasound imaging with mini-
mal distortion or creation of artifact in the ultrasound image.10 This was im-
plemented by manufacturing the port body and the sleeves out of
polyvinylidene fluoride, or ‘‘Kynar,’’ which is compatible with the ultra-
sound beam because it does not lead to ultrasound reverberations and arti-
fact. The advantage of this feature is that the risk of injury to nearby
intracardiac structures is minimized if the cardioport can be imaged as it
penetrates the cardiac wall and is positioned within the cardiac chamber.Port Operation
First, the port body with an obturator is inserted into the heart through
a purse-string suture. Then, a tool sleeve, selected for a particular instru-
ment or device, is inserted into the port body. The instrument is inserted
into the tool sleeve and pushed forward until the distal tip of the instrumentwing the key components of the fluid purging and valve systems. B, Actual
e intracardiac tip of the cardioport.
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FIGURE 2. Water tank port testing under 3D echocardiography. A, After
Vasilyev et al Evolving Technology/Basic Sciencehas just reached the valve located at the distal end of the port body. Then, to
remove air bubbles, an active fluid purging system is activated inside the
instrument and the port (Video 1). The fluid inflow of the system is con-
nected to the port body, and the outflow is connected to an instrument
via Luer lock connection. Standard wall suction is applied at the outflow
on the instrument, and a fluid reservoir (heparinized saline) is connected
to the inflow. When the system is activated, the suction is applied through
and around the instrument via the tool sleeve. This induces rapid flow of
saline from a reservoir through the gap between the port body and the
tool sleeve and through the instrument to ensure complete de-airing. The
valve at the end of the cardioport body prevents blood from entering the
port while fluid is circulating. Complete purging of the port and instrument
is completed in approximately 5 seconds. After purging, the instrument is
inserted inside the heart and used for surgical manipulations. This maneu-
ver is repeated each time an instrument or device is inserted into the heart.
After the procedure is completed, the cardioport is removed, and the purse-
string suture is tied in a standard manner.
Ex Vivo Testing
The repeatability tests were conducted in a water tank equipped with ul-
trasound imaging. Effectiveness of air bubble removal, sturdiness of the
port components, surgical ergonomics, and ease of port operation were
evaluated. The port and presence of air bubbles were visualized by
2-dimensional (2D) and 3-dimensional (3D) echocardiography using the
X4 matrix transducer on a SONOS 7500 system (Philips Healthcare, And-
over, Mass). A standard 9F introducer sheath (Arrow International, Read-
ing, Pa) was used as a control.
Animal Trials
The experimental protocol was approved by the Children’s Hospital
Boston Institutional Animal Care and Use Committee. All animals re-
ceived humane care in accordance with the 1996 Guide for the Care and
Use of Laboratory Animals recommended by the US National Institute
of Health.
In Yorkshire pigs weighing 60 to 70 kg (n ¼ 5), beating-heart interven-
tions such as atrial septal defect closure, VSD closure, and mitral valve re-
pair were modeled as previously described.7,11,12 Briefly, animals were
anesthetized by intramuscular injection of tiletamine/zolazepam (7 mg/
kg) and xylazine (4 mg/kg), and intubated with a cuffed endotracheal
tube and ventilated with a pressure control ventilator (Healthdyne 105;
Healthdyne Technologies, Marietta, Ga). Anesthesia was maintained
with 2% to 3% isoflurane. A median sternotomy or left side
thoracotomy was performed; a few stay sutures were placed on the
pericardium to optimize access to the cardiac chambers. Epicardial 2D
and 3D echocardiography were used for procedure imaging and air
bubbles visualization with the X7-2 matrix transducer on an IE33 system
(Philips Healthcare, Andover, Mass). Purse-string sutures of 3-0 or 4-0
polypropylene were placed on the heart wall for the cardioport insertion
into the each chamber. After intravenous heparin administration (100 U/
kg), the port was introduced into both right and left atria and ventricles. Ef-
fectiveness of air removal, occurrence of bleeding during port and instru-
ment manipulations, and surgical ergonomics were tested. Introduction
of the instruments through a conventional 9F sheath and through the
port, both after prior flushing but without use of the fluid purging system,
served as a control.de-airing the port, no bubbles are present. B, Control:Without de-airing the
port, large bubbles are present. C, Control with an introducer sheath: Mul-
tiple large bubbles are present. Cardioport (blue dashed line); introducer
sheath (green dashed line); air bubbles detected (red dotted circle). The di-
rection (arrow) of the instrument insertion.
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SRESULTS
Ex Vivo Testing
For each tool sleeve (n ¼ 3), we inserted the tool,
purged it, and then imaged the tip of the port as the tool
passed through the end valve. This was repeated 50 times
for each sleeve. All the components of the port systemThe Journal of Thoracic and Cardiovascular Surgery c Volume 142, Number 6 1547
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Swere operable throughout the tests. No air bubbles were
visualized by 2D and 3D ultrasound. In contrast, we de-
tected air bubbles after every tool insertion when using
the conventional introducer or the unpurged port system
(Figure 2).
Large Animal Experiments
Five series of trials were performed. In the first experi-
ment, the port was introduced into the left ventricle, and op-
erational durability of the system was tested in the presence
of blood, inside the high-pressure chamber, without intro-
duction of instruments. In all the subsequent experiments
(N ¼ 4), the port was introduced into each of the 4 cardiac
chambers, and instruments for beating-heart procedures
were introduced (Figure 3). We used the modified instru-
ments that were previously developed for atrial septal defect
and VSD patch closure and for mitral valve repair.7,11,12 In
particular, our tissue anchor deployment device was
modified by adding the features for fluid flushing through
its shaft.
Air was completely removed in all the instrument inser-
tions (6–10 trials per chamber), and 2D and 3D ultrasound
images showed no air emboli. In contrast, air emboli were
detected in 40% to 85% of the cases of instruments inser-
tion without use of the purge system (Figure 4, Video 1).
Port operation exhibited excellent surgical ergonomics,
and single-handed control and stabilization of the port
was observed in all the animal trials. Instrument introduc-
tion and exchange were fast and smooth. The operator
was able to reach all the desired intracardiac structures
with the cardioport, without injury to the heart wall. No
bleeding occurred in any of the cases throughout the proce-
dure, during port placement, instruments introduction and
exchanges, and port removal.
Cardioscopy Port
The cardioport can also be coupled to an imaging sys-
tem, such as a conventional optical telescope for direct vi-
sualization or even an ultrasound crystal array for
ultrasound imaging. After our initial experience with
cardioscopy-assisted beating-heart procedures,11 we have
designed a next-generation cardioscopy port that combines
the features of the current cardioport system with addi-
tional optical imaging (Figure 5). The 14-mm cardioport
was manufactured out of implantable grade PolyEtherE-
therKetone. The inner compartment of the port has an ex-
changeable transparent plastic bulb at the end. It housesGURE 3. The port introduction into the left ventricle during 3D
hocardiography-guided muscular VSD closure. A, Port body is inserted.
Sleeve is being inserted. C, Port is fully assembled. D and E, The instru-
ent, the anchor deployment device, is inserted into the port, the system is
shed, and the instrument is introduced into the left ventricle.
gery c December 2011
FIGURE 4. Intraoperative epicardial 3D echocardiography. A, VSD closure: Cardioport is inserted through the apex of the left ventricle, and the active
fluid purging system is used; no air bubbles are detected. B, Atrial septal defect closure: Standard introducer sheath is used after prior flushing; air bubbles
are detected. Cardioport (blue dashed line); introducer sheath (green dashed line); air bubbles detected (red dotted circle). The direction (arrow) of the in-
strument insertion. RA, Right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle.
Vasilyev et al Evolving Technology/Basic Sciencea standard 5-mm telescope for imaging. The bulbs with
various geometries can be mounted on the tip of the port
depending on the procedure. The outer working channel
is 3 mm in diameter and used for instrument access. The
port was designed for a particular set of instruments,
which eliminated the need for tool sleeves. The valve
and fluid purging systems were successfully adapted
from the current cardioport.FIGURE 5. Next-generation cardioscopy port. A, Schematic drawing of
the port showing exchangeable transparent plastic bulbs. B, Actual port
with the spherical bulb.
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With recent advancements in intracardiac devices and
imaging technologies, a growing variety of instruments
have been used inside the beating heart. This includes not
only traditional stent-based devices but also more complex
instruments, such as graspers, staplers, and patch deploy-
ment systems.2 Despite the growing number and complex-
ity of procedures, there are few if any available universal
cardioport systems that facilitate safe and effective instru-
ments introduction and exchange.
Our group has previously reported the use of modified
ports developed for other port-access procedures, such as
thoracoscopic or laparoscopic surgery, and used them for
intracardiac beating-heart, image-guided interventions in
an experimental setting.13 However, after initial promising
results, we found that such ports were not optimal for the
work requirements of beating-heart transcardiac interven-
tions, primarily because of the risk of air embolism dur-
ing instrument introduction. Similar findings have been
reported by others. Downing and colleagues14 tested
a 15-mm custom-designed port in beating-heart mitral
valve repair, where the port was introduced into the left
atrium. Although the port worked adequately allowing
the procedure to be completed, air introduction was en-
countered in all 6 animals: minimal in 2, mild in 3, and
moderate in 1.
Other investigators have proposed a universal system for
instrument introduction. Guiraudon and colleagues15 devel-
oped the universal cardiac introducer made of vascular graft
material and assembled out of 2 components: an attachment
cuff and an airlock chamber with up to 4 sleeves for intro-
duction of various instruments and devices. The cuff is su-
tured to the cardiac wall, and intracardiac access is
controlled with a vascular clamp. Instrument access inside
the sleeves is controlled with snares. The airlock chamber
acts as an air bubble trap, with the sleeves positioneddiovascular Surgery c Volume 142, Number 6 1549
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Svertically well above the heart port access. A saline line is
connected to the airlock chamber to assist with de-airing.
This port system is characterized by significant size and
complexity. In addition, it may be challenging to use such
a design for access into the high-pressure cardiac chambers,
especially the left ventricle.
The advantage of our system is that an active fluid purg-
ing system is used, which ensures complete elimination of
air bubbles from the instrument shaft before its entry into
the cardiac chamber. Furthermore, the valve system pre-
vents bleeding during instrument introduction and ex-
changes and allows port placement into high-pressure
chambers from various angles, which may be necessary dur-
ing image-guided, beating-heart transcardiac procedures.
When the fluid purging system is enabled, the pressure in
the port body becomes less than the pressure in the cardiac
chambers. The compliant trileaflet valve was designed to
exploit this pressure differential to seal against blood loss.
In fact, as the pressure differential increases the seal be-
comes even stronger because of the design of the compliant
valve’s shape. It should be noted that the internal volume of
the port body was also minimized to prevent blood loss dur-
ing tool insertion and operation when the trileaflet valve is
open. Furthermore, the availability of different size instru-
ment sleeves allows the use of most conventional instru-
ments and novel devices to be introduced via the port. In
addition, although the current cardioport diameter is large,
it can be reduced substantially for introduction into higher
pressure chambers, such as the left ventricle, which will fur-
ther reduce the size of the defect at the site of port introduc-
tion into the heart.
Additional important functionality of the cardioport sys-
tem is to incorporate optical imaging. Video-assisted car-
dioscopy using visible wavelength light provides
detailed, high-magnification imaging of the tools and the
target. However, use of visible wavelength light requires
that blood be physically displaced between the optical
window of the cardioport and the target structures. This re-
sults in a limited field of view. Although the described
procedures can be performed in the beating heart with
the current system, use of infrared light may improve
the field of view. Infrared light permits limited transmis-
sion through blood,16 but the depth of field of the current
infrared systems is still less than 1 to 2 cm, making nav-
igation through the cardiac structures difficult. An addi-
tional limitation of the current infrared systems is that
they have a relatively low frame rate because of the image
processing time required, which makes visualization of
rapidly moving structures, such as heart valves, difficult.
Some of these limitations may be overcome by redesign-
ing the location of the infrared light detector, which re-
duces light loss through the transmission fibers. If
implemented, this may enable 2- or multiple-port opera-
tion inside the beating heart. Moreover, it would open1550 The Journal of Thoracic and Cardiovascular Sura possibility of designing multifunctional tools for
beating-heart intracardiac interventions, such as developed
for gastroenterologic procedures.17 As for current proce-
dures, we believe that the key to success in safe navigation
inside the beating heart is still to use combined, or hybrid,
imaging. Fluoroscopy provides a ‘‘big picture’’ view for
navigation toward cardiac chambers, and 3D echocardiog-
raphy can give surgeons superior large-volume spatial
orientation, whereas cardioscopy offers a detailed, high-
magnification view of the tool as it interacts with the target
structure.CONCLUSIONS
We have developed a novel cardioport system for the safe
and easy introduction of surgical tools into all the cardiac
chambers. Use of the port improves safety of beating-
heart procedures and facilitates further development of
more complex instruments and devices. This technology
may be an enabling platform for intracardiac image-
guided, beating-heart surgery.References
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